NDC 62332-405

Silodosin

Silodosin

Silodosin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Silodosin.

Product ID62332-405_bb7f7a35-fb22-4568-883b-9a8def59faef
NDC62332-405
Product TypeHuman Prescription Drug
Proprietary NameSilodosin
Generic NameSilodosin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-11-25
Marketing CategoryANDA /
Application NumberANDA211731
Labeler NameAlembic Pharmaceuticals Inc.
Substance NameSILODOSIN
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 62332-405-91

1000 CAPSULE in 1 BOTTLE (62332-405-91)
Marketing Start Date2019-11-25
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Silodosin" or generic name "Silodosin"

NDCBrand NameGeneric Name
0023-6142RAPAFLOsilodosin
0023-6147RAPAFLOsilodosin
52544-151RAPAFLOsilodosin
52544-152RAPAFLOsilodosin
0781-2623SilodosinSilodosin
0781-2624SilodosinSilodosin
27241-144SilodosinSilodosin
27241-145SilodosinSilodosin
33342-384SilodosinSilodosin
33342-385SilodosinSilodosin
59651-095SILODOSINSILODOSIN
59651-096SILODOSINSILODOSIN
68180-740SilodosinSilodosin
68180-741SilodosinSilodosin
69238-1420SilodosinSilodosin
69238-1421SilodosinSilodosin
69539-052SILODOSINSILODOSIN
69539-053SILODOSINSILODOSIN
72205-009SILODOSINSILODOSIN
72205-010SILODOSINSILODOSIN
62332-405SilodosinSilodosin
62332-406SilodosinSilodosin

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.